Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
D Taieb, GB Wanna, M Ahmad… - The Lancet. Diabetes …, 2023 - amu.hal.science
Patients with germline succinate dehydrogenase subunit D gene (SDHD) pathogenic
variants (ie, paraganglioma 1 syndrome/PGL1) are predominantly affected by head and …
variants (ie, paraganglioma 1 syndrome/PGL1) are predominantly affected by head and …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
D Taïeb, GB Wanna, M Ahmad… - The lancet. Diabetes …, 2023 - europepmc.org
Patients with germline succinate dehydrogenase subunit D gene (SDHD) pathogenic
variants (ie, paraganglioma 1 syndrome/PGL1) are predominantly affected by head and …
variants (ie, paraganglioma 1 syndrome/PGL1) are predominantly affected by head and …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
D Taïeb, GB Wanna, M Ahmad… - The Lancet …, 2023 - scholarlypublications …
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
D Taïeb, GB Wanna, M Ahmad… - … lancet. Diabetes & …, 2023 - pubmed.ncbi.nlm.nih.gov
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
D Taïeb, GB Wanna, M Ahmad… - The Lancet …, 2023 - researchwithrutgers.com
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
D Taieb, GB Wanna, M Ahmad… - The Lancet. Diabetes & …, 2023 - hal.science
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
D Taïeb, GB Wanna, M Ahmad… - The Lancet. Diabetes & …, 2023 - zora.uzh.ch
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
D Taïeb, GB Wanna, M Ahmad… - The Lancet Diabetes …, 2023 - research.rug.nl
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
[PDF][PDF] Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
EL par la Ligue - 2023 - researchgate.net
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …